questions on pharma promotion
the best laid plans of mice and marketing firms
this is the new booster/vaccine update marketing out from the FDA
obviously, there are A LOT of questions here:
does it even work in any clinical fashion?
is the proxy data of “greater titer expression in mice” even valid? (especially when we don’t even know what titer they used)
does that even apply to humans?
would this add perhaps be more honest?
or perhaps even this?
and so many other questions remain.
should we listen to tony fauci “now”?
or tony fauci “then”?
or tony fauci way back when?
so many questions, so few answers.
so many assurances
yet so little track record to be assured about.
so many changes of tune
and so many failures of duty and suppressions of fact.
how is one to do anything but question this?
and are we even asking the correct questions?
because amidst all the data deception and programmatic posturing sometimes we can lose sight of that upon which we ought to be focused.
i would posit that perhaps this is the question that really ought be asked:
because that one sure is a doozie once you hear it, isn’t it?
public health and drug regulation is intended to protect the populace from slipshod safety and abusive practice by pharma.
at least, that’s what they tell us.
but to those steeped in the fine tradition of “ignore what they say and watch what they do,” this is becoming exceedingly hard to swallow.
we can argue about what to call the current practices at the FDA, but it’s certainly not going to be “safeguarding the public,” is it?